Identificación de nuevos genes de susceptibilidad implicados en Cáncer de Mama familiar mediante técnicas de secuenciación masiva

Breast cancer (BC) is the second leading cancer-related death cause among women worldwide. Around 50% of the familial BC cases are reckoned to be inflicted by germline variants in known susceptibility genes, nevertheless, the other half is still of unknown genetic origin. With the raise of the Next-...

ver descrição completa

Detalhes bibliográficos
Autor: Marchena Perea, Erik Michel
Formato: tesis doctoral
Fecha de publicación:2024
País:España
Recursos:Universidad Complutense de Madrid (UCM)
Repositorio:Docta Complutense
Idioma:español
OAI Identifier:oai:docta.ucm.es:20.500.14352/110535
Acesso em linha:https://hdl.handle.net/20.500.14352/110535
Access Level:acceso abierto
Palavra-chave:611.69(043.2)
Mamas
Breast
Cancer
Ginecología y obstetricia
Oncología
3201.08 Ginecología
3207.13 Oncología
Descrição
Resumo:Breast cancer (BC) is the second leading cancer-related death cause among women worldwide. Around 50% of the familial BC cases are reckoned to be inflicted by germline variants in known susceptibility genes, nevertheless, the other half is still of unknown genetic origin. With the raise of the Next-Generation Sequencing (NGS) technology the successful finding of the missing susceptibility genes is closer. Therefore, the major aim of this Thesis was to study a panel of 17 susceptibility candidate genes in hereditary BC through the sequencing of more than 2200 Spanish familial BC patients that had previously been tested negative for the known BC susceptibility genes (BRCAX) and uncover the most promising...